|
Watson gets FDA approval for generic asthma drug
Businessweek PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Wednesday it received U.S. approval for its generic version of Pulmicort, an inhalable drug used to treat cough and breathing problems caused by asthma and lung disease. FDA approves Watson asthma generic Watson's Generic Version of Pulmicort RESPULES® Receives FDA Approval |
View full post on asthma – Google News